Home / Benchmarks / Pharmacy
Pharmacy Valuation Multiples (2026)
EBITDA & revenue sale multiples, deal flow, and active acquirers - based on 237real disclosed M&A transactions in the pharmacy space. Run the calculator below to price your business at current multiples.
What multiple does a pharmacy sell for?
In the $5M-$25M EV range, a pharmacy sold at a median of 0.74x revenue (middle 50% of deals 0.37x-2.84x) across 12disclosed M&A transactions, 2018-2026, from SEC EDGAR filings and verified press releases. That is the population midpoint — your specific number depends on margins, growth, customer concentration, and owner-dependence.
Updated 2026-07-09 · 12 disclosed deals · source window 2018-2026
| Size bracket | Median EV/revenue | Typical range (IQR) | n |
|---|---|---|---|
| $5M-$25M EV | 0.74x | 0.37x-2.84x | 12 |
Aggregate population median for the size bracket - disclosed transactions only (SEC EDGAR + verified press releases), 2018-2026, n≥10 per cell. A precise figure for your business depends on margins, growth, customer concentration, and owner-dependence. See the full $5M-$25M EV breakdown →
Tracking the pharmacy market? Get a free email alert when a pharmacy business sells — the deal, the buyer, and the multiple it went for.
CPA, attorney, or advisor? Put this data on your own site — free embeddable multiples widget and calculator.
State of PharmacyM&A in 2026
The pharmacy M&A market is tracked across 237 disclosed transactions in the ExitValue.ai database (147 with EBITDA disclosed, 200 with revenue). The current market trend is stable.
Active acquirers include Fagron, Sycamore Partners Management, L.P., Sycamore Partners, Nautic Partners. Recent named transactions: University Compounding Pharmacy (2026); Walgreens Boots Alliance, Inc. (2025); Walgreens Boots Alliance (2025).
Premium valuations in pharmacy are driven by specialty / compounding mix above 30% (pbm rate cuts hit retail not specialty); ltc / closed-door book or 340b participation (recurring institutional revenue); urac or achc accreditation in place (pe platform prerequisite, not optional).
What compresses valuations: pure retail / generic-substitution exposure (pbm reimbursement compression priced in); dir fee exposure trending up (margin compression unfixable at single-location scale); single-payer concentration above 50% (pbm contract loss = practice unviability).
Source: SEC filings, EDGAR 8-K/S-4, and verified press releases. Run the calculator below to see the specific multiples that apply to your business.
Recent named M&A deals in pharmacy
Most-recent disclosed transactions. Click any deal for full detail (multiples, financials, source).
Sourced from SEC filings, EDGAR 8-K/S-4, and verified press releases.
Get an instant valuation for your pharmacy
Backed by the same 237 disclosed transactions, adjusted for your specific size and margin.
Get your full valuation analysis
12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
What drives a premium valuation
- ●Specialty / compounding mix above 30% (PBM rate cuts hit retail not specialty)
- ●LTC / closed-door book or 340B participation (recurring institutional revenue)
- ●URAC or ACHC accreditation in place (PE platform prerequisite, not optional)
What compresses valuation
- ●Pure retail / generic-substitution exposure (PBM reimbursement compression priced in)
- ●DIR fee exposure trending up (margin compression unfixable at single-location scale)
- ●Single-payer concentration above 50% (PBM contract loss = practice unviability)
Pharmacy valuation: common questions
What multiple does a pharmacy sell for?
In the $5M-$25M EV range, a pharmacy sold at a median of 0.74x revenue (middle 50% of deals 0.37x-2.84x) across 12 disclosed M&A transactions filed 2018-2026 (SEC EDGAR + verified press releases). That is the aggregate population midpoint for the size bracket; a precise figure for your specific business depends on margins, growth, customer concentration, and owner-dependence — run the ExitValue.ai pharmacy calculator for that.
How is a pharmacy business valued?
Pharmacy businesses are valued by benchmarking against comparable completed M&A transactions, then adjusting for the specific business. Owner-operator practices are typically priced on an earnings or seller-discretionary-earnings basis, while businesses at platform scale shift toward institutional earnings-multiple methodology. The ExitValue.ai engine selects the methodology that the comparable deal set actually used and adjusts for margin quality, growth, owner dependency, customer concentration, and recurring-revenue mix.
What drives pharmacy valuation?
The biggest value levers in pharmacy are recurring or repeat revenue, owner independence (the business runs without the founder), customer diversification (no single client dominates), a credible growth trajectory, and operating-margin quality relative to the vertical. In this space specifically, buyers pay up for specialty / compounding mix above 30% (pbm rate cuts hit retail not specialty); ltc / closed-door book or 340b participation (recurring institutional revenue); urac or achc accreditation in place (pe platform prerequisite, not optional).
How many pharmacy M&A deals are tracked?
ExitValue.ai tracks 237 disclosed pharmacy M&A transactions, 147 with EBITDA disclosed, 200 with revenue disclosed, sourced from SEC filings, EDGAR 8-K/S-4 documents, and verified press releases and refreshed daily. Current market trend: stable.
Who buys pharmacy businesses?
Pharmacy businesses are acquired by strategic acquirers (larger operators in the same space), and private-equity platforms and roll-up consolidators, and unknown. Recent named acquirers include Fagron, Sycamore Partners Management, L.P., Sycamore Partners, Nautic Partners.
What is my pharmacy business worth?
Run the ExitValue.ai pharmacy calculator to see your business priced against the 237 disclosed pharmacy transactions in the database. The engine applies adjustments for margin, growth, owner dependency, customer concentration, and recurring revenue mix to produce a tight range around the most-likely transaction value.
More on pharmacy valuations
- Value a medical practice
- Value a dental practice
- Value a veterinary practice
- Value a pharmacy· run the calculator
- Who buys pharmacy businesses?· active buyers
- Recent deal: University Compounding Pharmacy· comparable transaction
- Who acquired University Compounding Pharmacy?· buyer profile
- How to value a pharmacy· long-form guide
Methodology details: how ExitValue computes valuation ranges · full pharmacy calculator